Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Early hair loss may indicate prostate issues.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

% free PSA and urinary markers help better identify prostate cancer.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Finasteride reduces prostate size and PSA levels in young patients.

Finasteride treats hair loss and reduces prostate cancer risk.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Finasteride effectively treats baldness but may cause sexual side effects.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Certain drugs that block specific enzymes can help treat prostate diseases.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.